Penumbra Among Well-Insulated Companies From Ongoing Tariff Dynamics, Says Analyst

Penumbra Inc PEN stock is trading higher after the company reported better-than-expected first-quarter 2025 earnings and reaffirmed the 2025 forecast.The medical device company reported:Sales of $324.1 million, up 16.3% year over year (+16.9% in constant currency) and beating the consensus of$ 315.66 million.Adjusted EPS of 83 cents, beating the consensus of 67 cents.Revenue from global thrombectomy products grew to $226.5 million in the first quarter of 2025, an increase of 20.7%, or 21.2%, in constant cur ...